News

EN

[Completion of the 3rd NKCLM Burning] FILE

Followed by the 1st NKCLM Burning(August 19th 2020) and 2nd NKCLM Burning(September 25th 2020), NKCLM amount of sales made by NKCL Bio Group on September, had been completely burned on October 12th 2020. NKCLM burned amount, which is sales made on September: 366,163 NKCLM※ The Burning...

NKCL | 2020.10.12 | 조회 93

[Completion of the 2nd NKCLM Burning] FILE

Followed by the 1st NKCLM Burning taken place on August 19th 2020, NKCLM amount of sales made by NKCL Bio Group on August, had been completely burned on September 25th 2020. NKCLM burned amount, which is sales made on August: 129,628 NKCLM※ The Burning history can be found in Etherscan. (NKCLM ...

NKCL | 2020.09.25 | 조회 78

“NKCL will lead the popularization of Immune-Therapy using NK cells” FILE HOT

“We will build up Personalized-Immune Care Platform by enhancing people’s health using NK immune cell, as well as various products and programs.” said Shin Dong-Hwa the chairman of NKCL Bio Group.   NKCL Bio Group researches and develops immune cell therapy using NK immune...

NKCL | 2020.09.08 | 조회 129

NKCL Bio Group signed MOA with Qingdao Orthopedic Hospital for cooperation on Cell Culture. FILE

NKCL Bio Group Inc. has signed MOA on April 27 with Qingdao Orthopedic Hospital (颐生健骨伤医院) , a hospital affiliated with China-TSRH Association in China, for business cooperation. In line with the social distancing, the MOA signing was held in the form of real-time video conference,...

NKCL | 2020.09.03 | 조회 98

NKCL Bio Group will accelerate the cell therapy business in accordance with the implementation of the Advanced Regenerative Medicine Act FILE HOT

NKCL Bio Group, a Korean bio-company that research and develops immune cell therapy, is attracting attention as a beneficiary company of ‘the Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Bio-Pharmaceuticals' (hereinafter referred to as the Advanced M...

NKCL | 2020.08.31 | 조회 113

The Proposal for Advanced Regenerative Bio Law Enforcement Ordinance has passed the Cabinet meeting. “Uncertainties have been resolved for Bio Industry to boost the R&D” FILE

The Ministry of Food and Drug Safety and the Ministry of Health and Welfare announced on the 25th that the enactment of the Enforcement Decree of ‘The Act on the Safety and Support of Advanced Regenerative Medicine and Advanced Biopharmaceuticals' has passed the cabinet meeting. ...

NKCL | 2020.08.27 | 조회 74

NKCL Bio Group to open “NK Immune Cafe” on 70 locations in Korea, to lead the immune care market. FILE

As a company that researches immune cell therapy using NK immune cells, NKCL Bio Group targets the $100 billion Immune cell therapy market through its differentiated technological competitiveness. It is leading the mass production and popularization of NK Immune Cell and products throug...

NKCL | 2020.08.21 | 조회 67

NKCL Bio Group Inc. wins the Future Management Award 2020 Korea as a prominent bio-company FILE

NKCL Bio Group has won 2020 Korea Future Management Award in Promising Bio company category. Korea Future Management is to discover and honor the people, companies, and organizations who have outstanding competence in various section of the society, which is organized by The K...

NKCL | 2020.08.21 | 조회 53

[1st NKCLM burning completion announcement] FILE

[1st NKCLM burning completion announcement] 20 Million issued NKCLM, which is 20% of total 100 million issued NKCLM, has burned on August 19th, 2020. The burn up record can be checked through Etherscan.  (NKCLM incineration TxID: 0x260be5facdc7ad6bbcf5eab56915df9b83b001dc8edde9879c9cdbae8e4f...

NKCL | 2020.08.19 | 조회 79

[Project Announcement] NKCL Project direction: NKCLM Burning FILE

Hello. This is NKCL Bio Group Inc.1. Creating NKCLM EcosystemThe immune care products of NKCL Platform is only available in NKCLM, to strengthen the token economy. 2. NKCLM BurningIn order to stabilize the NKCLM’s market price, NKCLM burning will take place as promised. A part of foundatio...

NKCL | 2020.08.11 | 조회 72
[ 1 ] 2 3 4 5

NKCL     |     info@nkcl.io
ⓒ 2019 NKCL All rights reserved.